XGN - Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook
2023-08-07 08:09:44 ET
- Exagen press release ( NASDAQ: XGN ): Q2 GAAP EPS of -$0.28 beats by $0.21 .
- Revenue of $14.14M (+85.8% Y/Y) beats by $3.21M .
- Cash and cash equivalents were $31.5 million as of June 30, 2023, which reflects the $10 million principal prepayment we made when refinancing our debt on April 28 of this year and an increase in accounts receivable to $16.2 million.
-
2023 Guidance: We are providing revenue guidance for the third quarter of 2023 in the range of $10 million to $10.5 million.
For further details see:
Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook